William Ardrey
Director/Board Member bij Resistys, Inc.
Profiel
William J. Ardrey is een zakenman die aan het hoofd heeft gestaan van 12 verschillende bedrijven. Dr. Ardrey is lid van de raad van bestuur van Resistys, Inc. en professor aan de Universiteit van Adelaide, professor aan de George Washington University, professor aan de Universiteit van West-Australië en professor aan de Columbia University. In zijn vorige loopbaan was William J. Ardrey Voorzitter, President & Chief Executive Officer bij Avantogen Oncology, Inc, Chief Executive Officer bij Alcon, Inc, President & Non-Executive Director bij CustomVis Plc, President van LaserSight, Inc, Chief Executive Officer bij SciClone Pharmaceuticals, Inc, President bij Thomson Financial Services LLC, Voorzitter bij Solbec Pharmaceuticals Ltd., Chief Executive Officer bij Novartis, Inc., Chief Executive Officer van Acuvax Ltd., President bij Regenera Ltd., Chief Executive Officer van QLT, Inc. en Chief Executive Officer van Avantogen Ltd.
Actieve functies van William Ardrey
| Bedrijven | Functie | Begin |
|---|---|---|
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | 20-04-2009 |
| George Washington University | Corporate Officer/Principal | 20-04-2009 |
| University of Adelaide | Corporate Officer/Principal | 20-04-2009 |
Resistys, Inc.
 Resistys, Inc. Pharmaceuticals: MajorHealth Technology Part of Avantogen Oncology, Inc., Resistys, Inc. develops RP101, a pancreatic cancer drug aimed at preventing chemo-resistance for the North American market. The private company is based in Los Angeles, CA. | Director/Board Member | 06-12-2010 |
| The University of Western Australia | Corporate Officer/Principal | 16-09-2011 |
Eerdere bekende functies van William Ardrey
| Bedrijven | Functie | Einde |
|---|---|---|
Acuvax Ltd.
 Acuvax Ltd. Pharmaceuticals: OtherHealth Technology Acuvax Ltd. is engaged in the research and development of cancer therapies and virus and vaccine development in Australia and North America. It is in process of acquiring Biolife Science Ltd, which is developing a vaccine for breast and gastric cancers. The company is headquartered in West Perth, Australia. | President | 09-02-2011 |
| Solbec Pharmaceuticals Ltd. | Chairman | 08-12-2008 |
CustomVis Plc
 CustomVis Plc Medical SpecialtiesHealth Technology CustomVis Plc manufactured and sold laser optical equipment for use within the laser vision correction industry. The company's products included CustomVisTM and PULZAR Z1TM. It was founded in March 2001 and headquartered in Perth, Australia. | President | 22-05-2006 |
| Avantogen Ltd. | President | - |
| ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ALCON INC. | Health Technology |
| Bedrijven in privébezit | 13 |
|---|---|
SciClone Pharmaceuticals LLC
 SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology SciClone Pharmaceuticals LLC was engaged in the development of therapeutic treatment for oncology, infectious diseases, and cardiovascular disorders. It was also offering ZADAXIN for the treatment of hepatitis B, hepatitis C, certain cancers, and used as immune system enhancer, and DC Bead which is used for the novel treatment of liver cancer. The company was founded in 1990 and was headquartered in San Mateo, CA. | Health Technology |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
LaserSight, Inc.
 LaserSight, Inc. Electronic ComponentsElectronic Technology LaserSight, Inc. through its wholly-owned operating subsidiaries LaserSight Technologies, Inc. and LaserSight Patents, Inc engages in the development, manufacture & sale of ophthalmic lasers and related products primarily for use in laser vision correction, including laser in-situ keratomileusis & photorefractive keratectomy procedures. It also licenses patents related to refractive surgical procedures. The company was founded in 1987 and is headquartered in Winter Park, FL. | Electronic Technology |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Health Technology |
Hawaii Biotech, Inc.
 Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | Health Technology |
CustomVis Plc
CustomVis Plc Medical SpecialtiesHealth Technology CustomVis Plc manufactured and sold laser optical equipment for use within the laser vision correction industry. The company's products included CustomVisTM and PULZAR Z1TM. It was founded in March 2001 and headquartered in Perth, Australia. | Health Technology |
| Solbec Pharmaceuticals Ltd. | Health Technology |
Acuvax Ltd.
Acuvax Ltd. Pharmaceuticals: OtherHealth Technology Acuvax Ltd. is engaged in the research and development of cancer therapies and virus and vaccine development in Australia and North America. It is in process of acquiring Biolife Science Ltd, which is developing a vaccine for breast and gastric cancers. The company is headquartered in West Perth, Australia. | Health Technology |
| Regenera Ltd. | Commercial Services |
Resistys, Inc.
Resistys, Inc. Pharmaceuticals: MajorHealth Technology Part of Avantogen Oncology, Inc., Resistys, Inc. develops RP101, a pancreatic cancer drug aimed at preventing chemo-resistance for the North American market. The private company is based in Los Angeles, CA. | Health Technology |
Avantogen Oncology, Inc.
 Avantogen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Avantogen Oncology, Inc. operates as a development stage company. It is engaged in the acquisition and development of novel compounds to treat patients with various types of cancer. The company was founded in 1986 and is headquartered in Pasadena, CA. | Health Technology |
| Avantogen Ltd. | Commercial Services |
Thomson Financial Services LLC
 Thomson Financial Services LLC Life/Health InsuranceFinance Thomson Financial Services LLC offers insurance services. The firm assists employees on claim issues and educate on benefits of policies. It offers medical, dental, life, disability, and long term insurance services. The company is headquartered in Southington, CT. | Finance |
